Cineverse Corp. Files Q3 2025 10-Q

Ticker: CNVS · Form: 10-Q · Filed: Feb 14, 2025 · CIK: 1173204

Sentiment: neutral

Topics: 10-Q, quarterly-filing, company-information

Related Tickers: CNVS

TL;DR

Cineverse (CNVS) Q3 2025 10-Q filed. Address: NY. Formerly Cinedigm.

AI Summary

Cineverse Corp. filed its 10-Q for the period ending December 31, 2024, reporting on its third fiscal quarter of 2025. The company's business address is located at 224 W. 35th St., Suite 500, #947, New York, NY 10001. Cineverse Corp. was formerly known as Cinedigm Corp. and Cinedigm Digital Cinema Corp.

Why It Matters

This filing provides investors with an update on Cineverse Corp.'s financial performance and operational status for the third quarter of fiscal year 2025.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.

Key Players & Entities

FAQ

What is Cineverse Corp.'s fiscal year end?

Cineverse Corp.'s fiscal year ends on March 31st.

What was the previous name of Cineverse Corp.?

Cineverse Corp. was formerly known as Cinedigm Corp. and Cinedigm Digital Cinema Corp.

What is the filing date of this 10-Q?

This 10-Q was filed on February 14, 2025.

What period does this 10-Q cover?

This 10-Q covers the period ending December 31, 2024, which is the third fiscal quarter of 2025.

What is Cineverse Corp.'s business address?

Cineverse Corp.'s business address is 224 W. 35th St., Suite 500, #947, New York, NY 10001.

Filing Stats: 4,752 words · 19 min read · ~16 pages · Grade level 17.7 · Accepted 2025-02-14 17:00:28

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements (Unaudited) 1 Condensed Consolidated Balance Sheets at December 31, 2024 (unaudited) and March 31, 2024 1 Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2024 and 2023 2 Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and nine months ended December 31, 2024 and 2023 3 Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Equity for the three and nine months ended December 31, 2024 and 2023 6 Notes to the Condensed Consolidated Financial Statements (Unaudited) 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 4.

Controls and Procedures

Controls and Procedures 32

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 33 Item 1A.

Risk Factors

Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 33 Item 3. Defaults Upon Senior Securities 33 Item 4. Mine Safety Disclosures 33 Item 5. Other Information 33 Item 6. Exhibits 34 Exhibit Index 34

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS (UNAUDITED)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED) Cineverse Corp. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) As of December 31, 2024 March 31, 2024 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 6,083 $ 5,167 Accounts receivable, net of allowance for credit losses of $ 151 and $ 269 , respectively 33,938 15,106 Employee retention tax credit 79 1,671 Content advances 8,825 9,345 Other current assets 1,559 1,432 Total current assets 50,484 32,721 Property and equipment, net 2,927 2,276 Intangible assets, net 17,840 18,328 Goodwill 6,799 6,799 Content advances, net of current portion 1,431 2,551 Other long-term assets 1,061 1,703 Total Assets $ 80,542 $ 64,378 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued expenses $ 35,974 $ 20,817 Line of credit, including unamortized debt issuance costs of $ 153 and $ 81 , respectively 3,847 6,301 Current portion of deferred consideration on purchase of business 3,369 3,114 Earnout consideration on purchase of business — 180 Current portion of operating lease liabilities 207 401 Deferred revenue 331 436 Total current liabilities 43,728 31,249 Deferred consideration on purchase of business, net of current portion — 457 Operating lease liabilities, net of current portion 324 462 Other long-term liabilities 27 59 Total Liabilities $ 44,079 $ 32,227 Commitments and contingencies (see Note 6) Stockholders' Equity Preferred stock, 15,000,000 shares authorized; Series A 10 % - $ 0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at December 31, 2024 and March 31, 2024 3,559 3,559 Common Stock, $ 0.001 par value; Class A Stock: 275,000,000 shares authorized as of December 31, 2024 and March 31, 2024; 16,462,308 and 15,985,620 share

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing